Dr. Luay Alshara, MD

Dr. Alshara practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Alshara's NPI, 1902226863, was assigned on April 18, 2014. Dr. Alshara graduated from University of Baghdad College of Medicine in 1999. Dr. Alshara holds Ohio license 35.131969.

Dr. Alshara's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Alshara's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. Dr. Alshara is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Alshara to 2 more clinical labs and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alshara practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Alshara's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Alshara is licensed in Ohio.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and kidney stones among the conditions Dr. Alshara treats.

CMS data shows 209 Medicare services from Dr. Alshara across 7 procedure codes in 2024, for 164 Medicare patients. Medicare paid $14,368 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 164 Medicare patients who saw Dr. Alshara in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alshara's median patient age at 63, with 29% women.

In 2024, Dr. Alshara wrote 506 Medicare Part D claims for 129 patients. 89% of them were for generic drugs. CMS names the drug for 430 of them, across 11 drugs with 11 or more claims each, at $36,182 in total drug cost. In 2023, CMS named 685 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Alshara for performance year 2024, reported as part of a group. Dr. Alshara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alshara as offering telehealth. CMS counts 29 procedures of prostate resection by Dr. Alshara, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Alshara, published from 2016 to 2023. 2018 was the busiest year, with 2. The most frequent topics are Kidney Calculi, Ureteroscopy and Postoperative Complications. Dr. Alshara has published most often in J Endourol. Dr. Alshara's most frequent co-authors are Manoj Monga, MD, Nishant D. Patel, MD and Seth K. Bechis, MD.

Dmand AI links Dr. Alshara to 1 clinical trial. Conditions studied include Ureteral Calculi and Ureterolithiasis.

CMS Open Payments shows 43 general payments to Dr. Alshara from 10 drug and device companies from 2018 to 2025. Travel and lodging make up the largest share, 56% of the total. Boston Scientific Corporation paid the most, $3,058.

Dr. Alshara graduated from University of Baghdad College of Medicine in 1999.

Dr. Alshara is in network with 12 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.